CinCor Pharma

YTD

ALL

Why Robinhood?

You can watch CinCor Pharma and buy or sell other stocks, options, and ETFs commission-free!

About CINC

CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease.

CEO

Marc M. P. de Garidel, EMBA

CEOMarc M. P. de Garidel, EMBA

Employees

—

Employees—

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2018

Founded2018

Employees

—

Employees—

CINC Key Statistics

Market cap

1.27B

Market cap1.27B

Price-Earnings ratio

-12.67

Price-Earnings ratio-12.67

Dividend yield

—

Dividend yield—

Average volume

1.20M

Average volume1.20M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$43.15

52 Week high$43.15

52 Week low

$10.53

52 Week low$10.53